2017 2017 As Asse sess ssment t of of Loc ocal al H Heal alth th De Depar artment t (LHD) I Immunization on Progr ograms s National Association of County & City Health Officials
NACCHO National Assoc iation of County& Ci ty Health Officia ls The National Association of County and City Health Officials (NACCHO), with funding and support from the Centers for Disease Control and Prevention (CDC), intend to conduct an assessment of Local Health Departments (LHDs) to identify and explore the many facets of their efforts to address immunization and vaccine preventable diseases. Every three years, NACCHO produces the National Profile of Local Health Departments which provides a comprehensive description of LHD infrastructure and practice. While this profile does include immunization services, it does so only at a very high level. The 2017 NACCHO Annual Immunization Survey will provide insight into the status of immunization programs at the LHD level, characterize their activities to control vaccine preventable diseases and provide immunization services within their jurisdictions, as well as identify possible challenges and/or best practices experienced by LHD immunization programs. Based on the input of the NACCHO Immunization Workgroup, the survey will specifically inquire about LHD immunization funding, policies, health education and community outreach, Vaccines for Children and 317 immunization services, VPD case investigation and control efforts, and the use of immunization information systems. Overall, the assessment will collect information to support and promote the role of immunization programs and services within the LHD.
Roll Call NACCHO National Association of County& City Health Officials Sean Dade John Douglas Carrie Harter Alexandra Hayes Shelia Hiddleson Alisa Johnson Athen Jacob Mbafor Libby Page Marisa Stanley Gillian Stoltman Tiffany Tate
~ ~ Advisory Committee on Immunization NACCHO Practices (ACIP) – Feb. 21-22, 2018 National Association of County& City Health Officials Fi nal - F ebruary 12, 20 18 MftTING OfTHE ADVISORY C OM MITTtE ON IM MUNI ZA TI ON PRACTICfS (AOP) Centers f or Olw!ilse Conuol ;w,d Prevention 1600Clfton Road , NE, Tom H;u tln Glob ill Corrvn unlc.atlom C:l!'ll ter, Kent • oz • Nelson Auditorium Atl anu,Geof"gl,a30329 Februarv ll -22, 2011 AG(NO.t,IT[M P RESIDER/PRESENTtR(sl Wednesdil'( February 21 a: oo w elcome & lntroductloM Dr . N ancy~nnett(AC IP Chalr) Dr . Amand a Cohn {AOP Executive Secr eta ry : CDC) 1:30 Hepa. tltls VKdnes I nt roduction Dr . J ose Romet"O jAC IP, WG Chair) Review of GRAtlE { HE P USAV -fl) Information Dr . A.Iron Ha rris (CDC/N01H STP) Considerations itnd proposed recommendations & Discussion Dr. Sar ah Sc hlllie (COC/NCHHST P) Vote Or .S ;m 1 hSc h ll l ie(CD< liep,atltlsApost-e,q>OSl.lf"e prop hylaldsGFtAOE In form ation Or. Noele N ehon (COC Fi nal • Fe b r u a ry 12, 2018 Considerations a nd proposed recommendations & Dlsc. u1. slon Or . Noele N ehon (CO( Thuryday F fbrua,yll Publlccomment Acenq, Updates & unf lNShed Busines s Vote Dr . Noele Nehon (CO( COC. CMS, DoO. O VA, FDA, H RSA, ! HS. N IH, NVPO lnformillion ::'~ Messonnler ICOC/NORO): CxOfflcio 10:30 ln fluenu Vaccines Pneum OCOCJCal Introduction Dr .Chlp wa1ter (AC• , lntrodoctlon Or . Grace l ee j ACIP , WG Chill rj PCV13 Effecdveness: Ca!ie Control S tudy Or. Tama ra P il ls h \11 11 (COC/NOIIOI FluilrllcQ~flvalent:effkiKYlnchldren6-35mon thsof a ge Dr . Leon;; u d frled~nd PCV13 Olrea and l nd l rea Effects ;,mon1 Adulu it6S Year Ol d Or. Tamara P il ls hvl ll (COC/NCIIIOI Survel ff anceupd,;ite M Ll y nnette B ramrm PCV13eff~agains l pneurnocoa:a l p n~rnonlaamona I nformation Or. J ohn M . McUough ln ! Pf izer V.acdnesl Information Dr . Brendan F~nne,y VE updiite &D iscussion U.S..Adulu Results of ;t random lzed tr ial of a new Hl Nl LAJVstrafn In US & Discussion Dr . Raburn Mallory(" Estl mat ln1 Burden of Pneumococ:ail Pneumon l.a amonc Adults Or. Almea Matilnoc:k {COC/NCI RO) chUd ren In the U .S.. PfoCJHS of l he research a gend a IO ln fo,m po l en ti.a l RevlewoflANfor2th rough l?vearolds Dr .UsaG roh skopf (Q po l icy change Fec-dinands (COCJ N C II 10:30 Y.acclnes and other blologks f« pre..e n llon and tr- t men t of Considerations a nd proposed recommeodatlons Dr.UsaGrohskopf(Q hoealt ha.re--a:ssoc:lated lnfect lom Public commen t Updu e l nfo rmillion Or. An l hony Flore !COC/N Cf.Z IOj VO~ V ote Dr .UsaGrohskopf{Ct VFCVote VFCVote Dr . Jean neSantol i 11: 30 Men lncoc:oc:ca lO lsease 12:CS Lundi Introduction -1!'S EvidenteBi1sedRe1:ommendiltlons Epidemiology of men l nsococcal dl!iease amonc cole1e s tudenu- U nited Stiltes.. 20 1 4-2016 I ntroduction Inf orm ation Dr . Grace L ee jAC IP, V Evidence to Recommendations Fr amework & Discussion Dr. Wendy Carr ICOCJ 12.:00 J ;,panese Encepha llds (JEI vaccine Publkcomment I nformation Or. Chip Walt er {ACIP, WG Chair ) Dr . WendyCarr (COCJ Review of JE ..cl work group pla m. & Olscu ulon Or. Susan Hih ICOC/NCf.Z IO) Z:.30 Anthru. 12.: IS Y.ac d neSuppty lnformillion Or. J eanne S;m1oll (COC/NC IRO ) lntroductk>n Dr . David Stephens{ A 12.:20 Pub lk: Comment Update on IM 1'01.lte of administration o fv acdne ln form auo n Dr . W iillamBower(a 12.:30 Adj oum ~ring 51rate,les when demand f o, vaccine excess &Disc ussion Dr.WiiliamBowe r (a ... .,...,,,, ..... Duration of a ntlmlaobla l component of PEP when u!ied In Dr .Wii llamBower (a ,oc combin at ion with anth r.u. vacdne Centl!fS for 01:sease Contro l & Preven1lon l~S Bre o lc ™ ' Cent l!fS ! or MedlCMe and Medkald Se-rvkes UJO Hllfflitn Pap ll lornalllrus (HPV) VlKC l nH Depart me nt of Defem;e OoO ,.,. Departme nt of Veter ans Affai rs lntroductk>n Or . PeterSzllagyl C AO OVA food and Drug Administration 9-valent HPV vaccine ~ fety da ta - VAfRS u pda te Or . lor gi.'Arana(CDC/ Grad l ns of Rec.omrnend;itlonsAs.soessment.. Development and fvaluallon GAAOE 9-valent HPY vaccine rapid cyde anaty,sk, Vaccine 5.afet-, I nform ation Or. /Im Dona hue (Ma t H'5A Health Rtiou rc es and Sef"llicl!s Admfnlslratlon Ka rmon lzatlon of upper ;iigefo, male and female vaccin ation & Discussion Or . Uu r1 Ma rtowitz II '"' recommen dations veroce ll cu Jt u re-dl!t"NedJapaneseencephallt ls Trends In HPY-allOCiated c.ancen. In the U nit ed St at es Or . Eli zabe th Yan Oyn N CH H ST P Na tiona l Center f« H IV , Hl!palltis, ST D and T8 Prevention (of COC/OIO) Natlon;,I Cente,r f« lm munlz;itlon & Rnplr;11tory Dlsulft lof COC/OIOJ Epldemlology of H P\' Infection In males Or.AnllCh;nun.oedl (N N CIRO N CE210 ~::::: : ~.,:: ~: t ~=l:l n1 and Zoonotlc Di seases lof COC/OtOJ 5.:30 Pub lk C.ornment NO s~s Ad ) oum N;itlon;,l lnU ltuieso f He;ilth N ationa l vaoc: l ne Pro1rMn Offke N V,O U-valenl pneumococca l conjugate vacdne ""' " VK Yudn~ f orChlld r en Wori<Group WG poplofl
National Vaccine Advisory Committee - NACCHO Feb. 7-8, 2018 National Association of County& City Health Officials Day 1 - Wednesday, February 7th Tim e Ag enda Item Pr es e nte r (s ) We lco me , Roll Call, and Rul es of Dr. Angela Shen , Designa t ed Federa l 9:00 - 9: 10 a. m. Engageme nt Officer Dr. Don Wright, Acting Assistant 9:rn - 9 :2 0 a. m. Opening Remarks Se cretary for Hea lth Day 2 - Thurs day , Febr uary 8th Dr. Me linda Wha rt on, Actin 9: 20 - 9 :3 0 a. m. NVPO Update NVP O Time Agenda It em Pre senter (s) Wel co me and Wrap Up from Pr evious NVAC Chair Up date 9:30 - 9:45 a.m. Dr. Kimberly Thompson, N 1 9: 00 _ 9:05 a.m . Dr. Ki mberly Tho mpson , NVAC C ha ir Da y 9 :45 a.m. - 12: 30 Update on Implementat io n of H PV 9 :05 - 10:15 a.m. NVAC Li aison and Ex Offi cio Updates p .m . Re co m men d at io ns Age ncy Highlight 20 17 -20 18 Flu Season Ms. Lynnette Brammer, CDC (presentation Ove rv iew: HPV Report Recommendations Or. Na lh an iel Sm ith, N VAC V 9: os - 9:15 a.m. 9: 45 - 10:00 a.m. Update via p ho ne) Su rv e ill an ce Upd ate and ov e rvi ew of C DC AHRQ, ASPR-BARDA, CDC, CMS, D oO , Dr. N an cy Me s so nni er , CDC 10:00 - 10:15 a.m. 9:15 - 9:45 a.m. Ex Officio Member Upda tes FDA, HR SA -BPHC, HR SA -DICP, IHS, A ct ivities NIH. US AI D, USDA. VA 10:15 - 10: 30 a.m. NCI Cancer Conlrol Re se arch Dr. Sarah Kob rin, NCI AC CV . ACIP, AHIP. AIM. AI RA, APhA, 9: 45 - 10:15 a.m. Liaison Member Updates ASTHO, NACC HO. PHAC, PAHO, NCl's Res earch Effo rt s on Reduced-dose Dr. John Schi ll er, NC I (on b ej VRBPAC 10:30 - 10: 45 a.m. HP V Vaccination Aimee Kreimer, NC I) Na ti onal Ad u lt and Infl uenza 10 :15 - 1 0:45 a.m. Immu nization Summit and Na ti o na l 10:4 5- 11 :00 a.m. HPV Case Study: Denver Hea lt h Dr. Ann a -Li sa Fa rm ar, DenvE Immun i za t io n Con feren ce :00 - 11 : 15 a,m, 11 Break Working Group Upd at es, 20 18 NA II S. and Or. Utjen Tan, IAC, on Behalf of NA IIS Co• 10:1 5- 10: 30 a.m. NIC Chairs (CDC, IAC, and NVPO) HP V Vaccination Initiatives at the Am erican Dr. D eb bie Sa slow, ACS (pre 11 :15 - 11 : 30 a.m. Ca ncer Socie ty pho ne ) 10:30 - 10:45 a.m. Discussion I 11 :30 a.m. - 12: 00 Round Robin: Pa rtn er Updates an d 10 :45 - 11 :OD a.m. Br eak p.m. Implementation Ac ti v iti es 11:00 a.m. - 12: 15 Disparities in Adult Immunizatio ns p.m . Dr. Anne Edwards, AA P Dr. P am ela G. R oc kw e ll , AA f Disparities in Adult Immunization - 2016 11:00 - 11 :15 a.m. Dr. R am Koppaka, CDC NHIS U nd er standing Dynamics Underlying Dr. Sandra Crouse Quinn, University of 11:1 5- 11 :30 a.m. Racial Disparities in In fl uenza Vaccination Ma ry land CMS Quality Innovation Network-Quality Improvement Organizations (QIN-QIOs) 11:30 - 11 :45 a.m. Improving Medicare Be ne fi ci ary Dr. Shiree So u th erland, CMS Immunizations Among Disparale Popula ti ons
Recommend
More recommend
